Literature DB >> 1788933

Efficacy of ivermectin against Parafilaria bovicola and lesion resolution in cattle.

G E Swan1, M D Soll, S J Gross.   

Abstract

Thirty-two cattle were included in a study to confirm the efficacy of ivermectin administered at 200 micrograms kg-1 against Parafilaria bovicola and to determine the time required for resolution of the lesions caused by the parasite. Four treated and four control animals were slaughtered over 2 days starting 15, 30, 50 or 70 days after treatment. The number, distribution and surface area of carcass lesions, and the weight of tissue trimmed to render the carcasses aesthetically acceptable, were recorded and parasites were recovered from subcutaneous tissues. Significantly (P less than 0.01) fewer worms were recovered from ivermectin-treated cattle slaughtered 50 or 70 days after treatment than from controls. Reductions in the mean number and surface area of lesions, and in the weight of tissue trimmed, were statistically significant (P less than 0.05) for the ivermectin-treated group slaughtered 70 days after treatment and approached significance (P less than 0.1) for the ivermectin group slaughtered 50 days after treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1788933     DOI: 10.1016/0304-4017(91)90106-6

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  2 in total

1.  Ivermectin treatment in an outbreak of cerebrospinal microfilariosis in goats in Saudi Arabia.

Authors:  O M Mahmoud; A Sulman; E M Haroun; E M Abdel-Magied; Y M Hameid; I A Ibrahim
Journal:  Trop Anim Health Prod       Date:  1994-08       Impact factor: 1.559

2.  Putative filariosis outbreak in white and black rhinoceros at Meru National Park in Kenya.

Authors:  Matthew Mutinda; Moses Otiende; Francis Gakuya; Linus Kariuki; Vincent Obanda; David Ndeere; Ephantus Ndambiri; Edward Kariuki; Isaac Lekolool; Ramón C Soriguer; Luca Rossi; Samer Alasaad
Journal:  Parasit Vectors       Date:  2012-09-19       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.